AIkido Pharma Inc (AIKI)

[BDEZ]

No Viewmont, have not heard anything.....loving this volume.

AIKI

[Viewmont]

It looks like as if insiders have good info about a drug getting close to be presented or something like that? Today's pre-market move to $1.70 rise was telling.
BDEZ, I haven't found any new news the last few days, have you?

[BDEZ]

Yes it does Viewmont, AIKI is on a roll!

[Viewmont]

Chart looks happy! http://schrts.co/sCbwekas

[Viewmont]

Yes I'd like that!

[ClayTrader]

* * $AIKI Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

[weedtrader420]

AIKI $3 Target price tomorrow hopefully pre-market tomorrow

[getyourownshares]

Jumper

[Viewmont]

AIKI has turned into BUY at Barchart.

Alkido Pharma Inc. (AIKI)
1.1800 +0.1500 (+14.56%) 15:59 ET [NASDAQ]
1.1200 x 2000 1.2200 x 100 REALTIME by (Cboe BZX)
BARCHART OPINION for Mon, Jul 20th, 2020Tutorial Alerts Watch Help
Overall Average:
24% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.

https://www.barchart.com/stocks/quotes/AIKI/opinion

[Viewmont]

This is the latest news I'm seeing out there. Insiders must know something. IMO.

AIkido Pharma Inc. Announces Key Progress in Computational Approaches to Identify Virus Treatments, Including Coronavirus.

https://finance.yahoo.com/news/aikido-pharma-inc-announces-key-173100000.html

[Viewmont]

I need AIKI to keep rising for a many, many months non stop!

[BluSkies]

Let’s hope so!

[weedtrader420]

It's going to start moving up quick $1.70 Target price

[weedtrader420]

Long time

[BluSkies]

AIKI do you love me?

[weedtrader420]

I'm ready for liftoff $1.70 in premarket WOW!

[INFINITI]

Time to load up

[INFINITI]

Thin here

[mining101]

Looking good

[posilock]

Is there any news?, why are we going up

[INFINITI]

Chase time

[INFINITI]

Let’s break that 52wk high

[INFINITI]

Looks mighty good here BAM$$$$

[PatrickTrader]

Good morning all...

[INFINITI]

Got my order in Bam

[jeffp123]

chart has looked better -

https://emerginggrowth.com/stat-news-adam-feuerstein-uses-up-his-nine-lives-on-cytodyn-otcqb-cydy/

[keekee]

Fools....fools and more fools and you wonder where do they get brains from...PIGS????

[keekee]

Lol.....money!
Money!!! Money!!! That's the deal...or the art of the deal with idiots learning the selling game!!! You BLINDFOLD THEM!!!!!

[INFINITI]

I have fidelity

[weedtrader420]

Double your money today

[glens0]

If you have Etrade you can buy now

[weedtrader420]

WeedTrader420 is a mastermind Trader WOOHOO$$$ AIKI to SPCE

[INFINITI]

Looks good buying at the open please don’t go to high lol

[weedtrader420]

Oh my God we're going to make so much fcking money holy moly Batman lmao woohooooooooooo

[weedtrader420]

WoW!

[georgie18]

AIKI...$1.28 in the P/M after hitting $1.70...:party:
[6:36 AM]
georgie1807/18/2020
AIKI...$1.03...Chart turning Very Bullish on the Consolidation Channel Breakout as the Bollinger Bands get stretched...adding on this Bullish Chart...
AIKI...tested the Break/Hold of the 200ma 3 times and failed...Monday it will Break/Hold the 200ma as well as flip the Psar to a Bullish Buy position on the Breakout...imo...we shall see... :party:

[Viewmont]

Something's happening with AIKI. Going up!

[Viewmont]

Went to 1.70, now coming back up for more!

[weedtrader420]

WOW!

[glens0]

1.61

[Viewmont]

AIKI @ $1.67 pre market. NICE!

[TrendTrade2016]

AIKI IS GARBAGE STAY AWAY!!

[Viewmont]

AIKI trading at $1.22 early pre-market!

[glens0]

AIKI 1.20 AH

[mick]

$AIKI THANK YOU , GOOD REPORE'

RE;
AIKI AIkido Pharma, Inc.
Shares Outstanding 34,920,200
Float 32,952,167
Insider Ownership 5.64%
Insitutional Ownership 18.10%

[glens0]

AIKI AIkido Pharma, Inc.
Shares Outstanding 34,920,200
Float 32,952,167
Insider Ownership 5.64%
Insitutional Ownership 18.10%

[Viewmont]

Nice chart georgie! Chart...http://schrts.co/nxCbhCuz

[Viewmont]

Just a reminder! AIkido Pharma Inc. Announces Key Progress in Computational Approaches to Identify Virus Treatments, Including Coronavirus
Research identified human protein complex that is important for viral replication
NEW YORK, July 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic. As previously announced, on April 13, 2020, AIkido executed a Master License Agreement with the University of Maryland, Baltimore ("UMB"), covering certain antiviral compounds discovered by UMB.

Recently, the researchers at UMB, including Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine (UMSOM), Alexander MacKerell, PhD, Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, and Stuart Weston, PhD, Postdoctoral Fellow at UMSOM, have identified a human protein complex (called the SKI complex) that is important for replication of several viruses including Influenza, COVID-19, SARS1, MERS, SARS2, Ebola and Marburg. Using a computer modeling approach called SILCS from SilcsBio LLC, chemical compounds were identified that are predicted to bind to a pocket on a human protein in this complex. These compounds were tested for their ability to block replication of the Influenza virus in human cells, from which several active compounds were found. These compounds were then tested against the other viruses and found to block replication of these as well. Utilizing the information gleaned from this initial research and the power of the SILCS technology combined with machine learning tools, the researchers are currently identifying compounds with chemical structures similar to the active compounds and testing them to find ones that work better at blocking virus replication.

"This is encouraging progress, demonstrating the importance of machine learning to accelerate pharmaceutical research," commented Anthony Hayes, CEO of AIkido. "Legacy processes, involving manually testing potentially thousands of compounds, are slower and potentially more expensive. Utilizing a combination of a physics-based approach and machine learning, our partners are able to significantly narrow the range of potential compounds to test, accelerating efforts and significantly reducing costs. The ultimate goal is to create a new compound that blocks replication of a wide variety of viruses in humans that will be an effective drug for the treatment of known viral infections as well as those that may arise in the future."

otcmarkets.com/stock/AIKI/news/story?e&id=1641643

[Viewmont]

Nice! All 3 BUY indicators.
https://www.tradingview.com/symbols/NASDAQ-AIKI/technicals/

[Viewmont]

Let's do this! https://www.tradingview.com/symbols/NASDAQ-AIKI/technicals/